STAA (Staar Surgical Co)
Insider Trading Activity
Every open-market purchase and sale reported by STAA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Warren Foust | President and CEO | MIXED | — | — |
| 2026-08-18 | DEBORAH J ANDREWS | Chief Financial Officer & EVP | MIXED | — | — |
| 2026-08-18 | Magda Michna | Chief Development Officer | MIXED | — | — |
| 2026-08-04 | Warren Foust | President and CEO | MIXED | — | — |
| 2026-08-04 | DEBORAH J ANDREWS | Chief Financial Officer & EVP | MIXED | — | — |
| 2026-06-23 | Christopher Min Fang Wang | Director | A | — | — |
| 2026-06-22 | Lilian Yansheng Zhou | Director | A | — | — |
| 2026-06-22 | Wei Jiang | Director | M | — | — |
| 2026-06-22 | LOU SILVERMAN | Director | M | — | — |
| 2026-06-22 | Richard T. LeBuhn | Director | A | — | — |
| 2026-06-22 | Arthur C Butcher | Director | M | — | — |
| 2026-06-22 | Neal C Bradsher | Director | A | — | — |
| 2026-06-15 | Lilian Yansheng Zhou | Director | A | — | — |
| 2026-05-19 | DEBORAH J ANDREWS | Interim Co-CEO and CFO | MIXED | — | — |
| 2026-05-19 | Warren Foust | Interim Co-CEO and Pres. & COO | MIXED | — | — |
| 2026-05-19 | Magda Michna | Chief Development Officer | MIXED | — | — |
| 2026-05-12 | Warren Foust | Interim Co-CEO and Pres. & COO | F | — | — |
| 2026-05-12 | Magda Michna | Chief Development Officer | F | — | — |
| 2026-03-16 | DEBORAH J ANDREWS | Interim Co-CEO and CFO | A | — | — |
| 2026-03-16 | Magda Michna | Chief Development Officer | MIXED | — | — |
| 2026-03-16 | Warren Foust | Interim Co-CEO and Pres. & COO | M | — | — |
| 2026-03-13 | Neal C Bradsher | Director | Buy | — | — |
| 2026-03-10 | Christopher Min Fang Wang | Director | A | — | — |
| 2026-03-10 | Neal C Bradsher | Director | A | — | — |
| 2026-03-10 | Richard T. LeBuhn | Director | A | — | — |
| 2026-02-04 | Warren Foust | Interim Co-CEO and Pres. & COO | A | — | — |
| 2026-02-04 | DEBORAH J ANDREWS | Interim Co-CEO and CFO | A | — | — |
| 2026-01-14 | Wei Jiang | Director | M | — | — |
| 2026-01-13 | BROADWOOD PARTNERS, L.P. | 10%+ Owner | Buy | — | — |
| 2026-01-08 | Neal C Bradsher | 10%+ Owner | Buy | — | — |
| 2025-12-12 | NATHANIEL SISITSKY | Chief Legal Officer | F | — | — |
| 2025-11-21 | BROADWOOD PARTNERS, L.P. | 10%+ Owner | Buy | — | — |
| 2025-11-14 | Wei Jiang | Director | M | — | — |
| 2025-08-13 | Wei Jiang | Director | M | — | — |
| 2025-06-26 | DEBORAH J ANDREWS | CFO | A | — | — |
| 2025-06-26 | Lilian Yansheng Zhou | Director | A | — | — |
| 2025-06-20 | Elizabeth Yeu Lin | Director | A | — | — |
| 2025-06-20 | Wei Jiang | Director | A | — | — |
| 2025-06-20 | Arthur C Butcher | Director | A | — | — |
| 2025-06-20 | LOU SILVERMAN | Director | A | — | — |
| 2025-06-20 | Lilian Yansheng Zhou | Director | A | — | — |
| 2025-05-14 | Magda Michna | Chief Development Officer | F | — | — |
| 2025-05-13 | Wei Jiang | Director | A | — | — |
| 2025-05-13 | LOU SILVERMAN | Director | A | — | — |
| 2025-04-10 | Neal C Bradsher | 10%+ Owner | Buy | — | — |
| 2025-04-07 | BROADWOOD CAPITAL INC | 10%+ Owner | Buy | — | — |
| 2025-04-02 | BROADWOOD CAPITAL INC | 10%+ Owner | Buy | — | — |
| 2025-03-28 | BROADWOOD PARTNERS, L.P. | 10%+ Owner | Buy | — | — |
| 2025-03-25 | BROADWOOD PARTNERS, L.P. | 10%+ Owner | Buy | — | — |
| 2025-03-20 | Neal C Bradsher | 10%+ Owner | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 31,016,786 | — |
| — | 10%+ Owner | 30,907,258 | — |
| — | 10%+ Owner | 26,526,474 | — |
| — | President, Int'l Operations | 1,140,000 | — |
| — | President and CEO | 283,839 | — |
| — | President & CEO | 146,224 | — |
| — | Director | 123,937 | — |
| — | Sr. VP Sales and Marketing | 112,990 | — |
| — | President and CEO | 86,556 | — |
| — | Sr. VP, Comm. Ops, China | 83,110 | — |
| — | Director | 77,127 | — |
| — | President & CEO | 70,519 | — |
| — | Director | 57,000 | — |
| — | Vice President, Switzerland Op | 56,500 | — |
| — | Chief Financial Officer | 56,242 | — |
| — | Director | 46,696 | — |
| — | Chief Legal Officer | 43,665 | — |
| — | Sr. VP, Comm. Ops., NA, APAC | 42,660 | — |
| — | Chief Medical Officer | 41,502 | — |
| — | Chief Development Officer | 41,161 | — |
| — | Vice President, R&D | 41,075 | — |
| — | Director | 40,000 | — |
| — | President, STAAR Japan Inc. | 40,000 | — |
| — | Chief Financial Officer & EVP | 36,339 | — |
| — | President & CEO | 35,156 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the STAA quote page; the site-wide leaderboard is on the insider transactions hub.